Biosynthesis of salsolinol, a tetrahydroisoquinoline alkaloid, in healthy subjects. 1990

P Dostert, and M S Benedetti, and V Bellotti, and C Allievi, and G Dordain
Farmitalia Carlo Erba Farmitalia Carlo Erba, Research and Development-Erbamont Group, Milan, Italy.

The R enantiomer of salsolinol was detected in the urine of two out of six healthy subjects, whereas 1,2-dehydrosalsolinol was present in the urine of all the subjects. (S)-salsolinol was never detected. Administration of Madopar for 7 days resulted in the presence of large amounts of (R)- and (S)-salsolinol in the urine of five out of the six subjects, the urinary excretion of 1,2-dehydrosalsolinol being generally not markedly increased. The presence of 1,2-dehydrosalsolinol in urine suggests that the biosynthesis of salsolinol in healthy volunteers should occur by condensation of dopamine with pyruvic acid, in keeping with Hahn's hypothesis. The absence of salsolinol in the urine of one subject after Madopar administration seems to indicate that the biological system(s) involved in the reduction of the C = N bond in 1,2-dehydrosalsolinol can be missing or not, or poorly, functional in some individuals, and suggests that there is no alternative pathway for the formation of salsolinol in healthy volunteers.

UI MeSH Term Description Entries
D007546 Isoquinolines A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
D007980 Levodopa The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. L-Dopa,3-Hydroxy-L-tyrosine,Dopaflex,Dopar,L-3,4-Dihydroxyphenylalanine,Larodopa,Levopa,3 Hydroxy L tyrosine,L 3,4 Dihydroxyphenylalanine,L Dopa
D008297 Male Males
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006834 Hydrazines Substituted derivatives of hydrazine (formula H2N-NH2). Hydrazide
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001545 Benserazide An inhibitor of DOPA DECARBOXYLASE that does not enter the central nervous system. It is often given with LEVODOPA in the treatment of parkinsonism to prevent the conversion of levodopa to dopamine in the periphery, thereby increasing the amount that reaches the central nervous system and reducing the required dose. It has no antiparkinson actions when given alone. Serazide,Seryltrihydroxybenzylhydrazine,DL-Serine 2-((2,3,4-trihydroxyphenyl)methyl)hydrazide,Ro 4-4602,Seryltrihydroxy Benzylhydrazine,Benzylhydrazine, Seryltrihydroxy,Ro 4 4602,Ro 44602

Related Publications

P Dostert, and M S Benedetti, and V Bellotti, and C Allievi, and G Dordain
January 2011, Chemical & pharmaceutical bulletin,
P Dostert, and M S Benedetti, and V Bellotti, and C Allievi, and G Dordain
June 2001, Free radical biology & medicine,
P Dostert, and M S Benedetti, and V Bellotti, and C Allievi, and G Dordain
January 2000, Journal of neural transmission (Vienna, Austria : 1996),
P Dostert, and M S Benedetti, and V Bellotti, and C Allievi, and G Dordain
January 1995, Alcohol (Fayetteville, N.Y.),
P Dostert, and M S Benedetti, and V Bellotti, and C Allievi, and G Dordain
January 2016, Current topics in medicinal chemistry,
P Dostert, and M S Benedetti, and V Bellotti, and C Allievi, and G Dordain
September 2007, Journal of biochemistry and molecular biology,
P Dostert, and M S Benedetti, and V Bellotti, and C Allievi, and G Dordain
January 1976, Lloydia,
P Dostert, and M S Benedetti, and V Bellotti, and C Allievi, and G Dordain
July 2017, Journal of natural products,
P Dostert, and M S Benedetti, and V Bellotti, and C Allievi, and G Dordain
June 2018, ACS chemical neuroscience,
Copied contents to your clipboard!